Insider Selling: Merge Healthcare CEO Sells 50,000 Shares of Stock (MRGE)
Merge Healthcare (NASDAQ:MRGE) CEO Justin C. Dearborn sold 50,000 shares of the company’s stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $2.34, for a total transaction of $117,000.00. Following the sale, the chief executive officer now directly owns 350,000 shares of the company’s stock, valued at approximately $819,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of Merge Healthcare (NASDAQ:MRGE) traded up 0.42% during mid-day trading on Monday, hitting $2.38. 413,759 shares of the company’s stock traded hands. Merge Healthcare has a 52 week low of $1.97 and a 52 week high of $2.98. The stock has a 50-day moving average of $2.35 and a 200-day moving average of $2.33. The company’s market cap is $227.7 million.
Merge Healthcare (NASDAQ:MRGE) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.05 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.02) by $0.07. The company had revenue of $53.80 million for the quarter, compared to the consensus estimate of $53.30 million. During the same quarter last year, the company posted $0.01 earnings per share. Merge Healthcare’s revenue was down 5.9% compared to the same quarter last year. Analysts expect that Merge Healthcare will post $0.15 EPS for the current fiscal year.
Separately, analysts at Topeka Capital Markets initiated coverage on shares of Merge Healthcare in a research note on Thursday, June 12th. They set a “buy” rating and a $3.00 price target on the stock.
Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.